Two recent reports have demonstrated that PRMT5 inhibition impairs DNA repair, enhances radiosensitivity in multiple CRPC cell lines, and prevents RT-induced neuroendocrine differentiation and tumor growth in CRPC-AR tumor models [278,279]. This evidence concerns the gene PRMT5 and neoplasm.